Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank79
3Y CAGR+22.0%
5Y CAGR+3.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+22.0%/yr
vs +21.8%/yr prior
5Y CAGR
+3.2%/yr
Recent acceleration
Acceleration
+0.2pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $134.93M | -12.4% |
| 2024 | $154.08M | -47.8% |
| 2023 | $295.39M | +297.3% |
| 2022 | $74.36M | -66.5% |
| 2021 | $221.97M | +92.6% |
| 2020 | $115.24M | +368.3% |
| 2019 | $24.61M | -27.1% |
| 2018 | $33.77M | -4.0% |
| 2017 | $35.17M | +47.5% |
| 2016 | $23.84M | - |